Procyon Advisors, LLC Cerus Corp Transaction History

Procyon Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$4.79 - $6.68 $80,328 - $112,023	-16,770 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$5.35 - $6.35 $27,675 - $32,848	-5,173 Reduced 23.57%	16,770 $99,000
Q1 2021 Apr 29, 2021	BUY	$5.68 - $7.87 $20,839 - $28,875	3,669 Added 20.08%	21,943 $132,000
Q4 2020 Jan 19, 2021	BUY	$5.25 - $8.56 $13,230 - $21,571	2,520 Added 16.0%	18,274 $126,000
Q3 2020 Oct 22, 2020	BUY	$5.78 - $7.47 $2,369 - $3,062	410 Added 2.67%	15,754 $99,000
Q2 2020 Aug 14, 2020	BUY	$4.5 - $7.02 $69,048 - $107,714	15,344 New	15,344 $101,000

160

144M

22.5K

23.6K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Procyon Advisors, LLC with notifications on news.